Early use of high efficacy therapies in pediatric forms of relapsing-remitting multiple sclerosis: A real-life observational study
Augustin Moreau, Ioanna Kolitsi, Laurent Kremer, Marie Fleury, Livia Lanotte, François Sellal, C. Gaultier, Guido Ahle, Sylvie Courtois, Andreas Fickl, Sohrab Mostoufizadeh, Christel Dentel, Nicolas Collongues, J. de Sèze, Kévin Bigaut
Topics & Concepts
MedicineGlatiramer acetateNatalizumabTeriflunomideFingolimodMultiple sclerosisDimethyl fumarateOcrelizumabClinical endpointInternal medicineAlemtuzumabObservational studyPopulationMcDonald criteriaPediatricsPhysical therapyRandomized controlled trialImmunologyRituximabEnvironmental healthLymphomaTransplantationMultiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersPolyomavirus and related diseases